Hormesis: Policy implications

Journal of Applied Toxicology

Volumn 20, Issue 2, 2000, Pages 141-145

  Lave, Lester B ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Delaney Clause; Hormesis; Mechanism of action; Risk analysis; Risk aversion

Indexed keywords

CARCINOGEN;

CONFERENCE PAPER; DOSE RESPONSE; ENVIRONMENTAL PROTECTION; HORMESIS; IMMUNE SYSTEM; OCCUPATIONAL EXPOSURE; POLICY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CARCINOGENS, ENVIRONMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; HUMANS; MODELS, BIOLOGICAL; PUBLIC HEALTH; RISK ASSESSMENT; UNITED STATES; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0034013334     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(200003/04)20:2<141::AID-JAT645>3.0.CO;2-0     Document Type: Conference Paper

References (24)

1. L. Lave, The Strategy of Social Regulation. The Brookings Institution, Washington, DC (1981).
2. P. B. Hutt and R. A. Merrill, Food and Drug Law. The Foundation Press, Westbury, NY (1991).
3. L. Lave and H. Dowlatabadi, Climate change: the effects of personal beliefs and scientific uncertainty. Environ. Sci. Technol. 27, 1962-1971 (1993).
4. L. Lave, F. Ennever, H. Rosenkranz and G. Omenn, Information value of the rodent bioassay. Nature 336, 631-633 (1988).
5. E. Anderson, and the Carcinogen Assessment Group of the US Environmental Protection Agency, Quantitative approaches in use to assess cancer risks. Risk Anal. 3, 277-295 (1983).
6. National Academy of Sciences, Risk Assessment in the Federal Government: Managing the Process. National Academy Press, Washington, DC (1983).
7. J. Graham, L. Green and M. Roberts, In Search of Safety: Chemicals and Cancer Risk. Harvard University Press, Cambridge, MA (1988).
8. US Environmental Protection Agency, Proposed New Carcinogen Risk Assessment Guidelines, 61 FR 17960 (1996).
9. R. Loehr and B. Weiss, Science Advisory Board Review of the draft document Alpha-2u Globulin: Association with Chemically Induced Renal Toxicity and Neoplasia: Association with Chemically Induced Renal Toxicity and Neoplasia in the Male Rat, EPA/625/3-91/019A. Letter to the Honorable William K. Reilly, EPA-SAB/LTR-EHC-91-006 (1991).
10. F. Miller and J. Kimbell, Regional dosimetry of inhaled reactive gases. In Concepts in Inhalation Toxicology, 2nd Edn, ed. by R. McClellan and R. Henderson, pp. 257-287. Taylor and Francis, Philadelphia, PA (1995).
11. M. Angell, Science on Trial: The Clash of Medical Evidence and the Law in the Breast Implant Case. Norton, New York (1997).
12. B. Fischhoff, Risk perception and communications unplugged: twenty years of progress. Risk Anal. 15, 137-145 (1995).
13. M. G. Morgan, B. Fischhoff, A. Bostrom, C. Atman and L. Lave, Communicating risk to the public. Environ. Sci. Technol. 26, 2048-2055 (1992).
14. J. Hammond, R. Keeney and H. Raiffa, Smart Choices. Harvard Business School, Cambridge, MA (1999).
15. C. Whipple (ed.), De Minimis Risk. Plenum Press, New York (1987).
16. G. E. Dinse, D. M. Urbach, A. J. Sasco, D. G. Hoel and D. L. Davis, Unexplained increases in cancer incidence in the United States from 1975 to 1994: possible sentinel health indicators? In Annual Review of Public Health, ed. by J. Fielding, L. Lave and B. Starfield, pp. 173-210. Annual Reviews, Palo Alto (1999).
17. R. Doll and R. Peto, The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Nat. Cancer Inst. 66, 1191-1256 (1981).
18. H. Kunreuther, and Richard Roth (eds), Paying the Price: The Status and Role of Insurance Against Natural Disasters in the United States. National Academy Press, Washington, DC (1998).
19. P. Slovic, B. Fischhoff and S. Lichtenstein, Rating the risks. Environment 21, 14-20 (1979).
20. D. Hoel and K. Crump, Waterborne carcinogens. In The Scientific Basis of Health and Safety Regulation, ed. by R. Crandall and L. Lave, pp. 173-196. Brookings Institution (1981).
21. J. Graham and J. Wiener (eds), Risk vs. Risk: Tradeoffs in Protecting Health and the Environment. Harvard University Press, Cambridge, MA (1995).
22. F. Ennever and L. Lave, Patient preferences and prenatal testing for neural tube defects. Epidemiology 6, 8-16 (1995).
23. G. Larick, FDA Commissioner, hearings before a subcommittee of the House Committee on Government Operations (1964).
24. Public Citizen v. Young, United States Court of Appeals, District of Columbia Circuit, 1987, 831 F.2d 1108.